Spin-off - BECTON DICKINSON & CO

Form Type: 8-K

Filing Date: 2025-02-05

Corporate Action: Spin-off

Type: New

Accession Number: 000001079525000019

Filing Summary: On February 5, 2025, Becton, Dickinson and Company (BD) announced that its board of directors has unanimously authorized management to pursue a plan to separate its Biosciences and Diagnostic Solutions business from the rest of the company. BD intends to provide more specifics regarding the separation plans by the end of fiscal 2025, targeting completion of the transaction in fiscal 2026. The separation is subject to various approvals and regulatory clearances, and there is no guarantee on the form, terms, or timing of the separation transaction.